Dr. Husa is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2045 N Franklin St
Denver, CO 80205Phone+1 303-338-4545
Education & Training
- University of California (San Diego) Medical CenterFellowship, Rheumatology, 2009 - 2012
- University of California (San Diego) Medical CenterResidency, Internal Medicine, 2006 - 2010
- Icahn School of Medicine at Mount SinaiClass of 2006
- Calvin College Health CenterB.S., Biology, With Honors, 1996 - 2000
- Calvin College Health CenterB.S., Biology, With Honors, 2000
Certifications & Licensure
- CA State Medical License 2008 - Present
- CO State Medical License 2016 - 2025
- OH State Medical License 2012 - 2016
- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- Patient-Centered Specialty Practice Recognition Program National Committee for Quality Assurance, 2014-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Chief Rheumatology Fellow UCSD Division of Rheumatology, 2011
- Join now to see all
Publications & Presentations
PubMed
- 56 citationsC/EBP homologous protein drives pro-catabolic responses in chondrocytesMatt Husa, Freyr Petursson, Martin Lotz, Robert Terkeltaub, Ru Liu-Bryan
Arthritis Research & Therapy. 2013-12-19 - 71 citationsShifting HIFs in osteoarthritis.M. Husa, Ru Liu-Bryan, Robert Terkeltaub
Nature Medicine. 2010-06-01 - 72 citationsLinked decreases in liver kinase B1 and AMP-activated protein kinase activity modulate matrix catabolic responses to biomechanical injury in chondrocytes.Freyr Petursson, Matt Husa, Ronald K. June, Martin Lotz, Robert Terkeltaub
Arthritis Research & Therapy. 2013-07-25
Journal Articles
- Jak 3, Severe Combined Immunodeficiency, and a New Class of Immunosuppressive DrugsPesu M, Candottie F, Husa M, Hofmann SR, Notarangelo LD, O’Shea JJ, Immunol Rev, 2/1/2005
- Jak3 and the Pathogenesis of Severe Combined ImmunodeficiencyO’Shea JJ, Husa M, Li D, Hofmann SR, Watford W, Roberts J, Buckley R, Changelian P, and Candotti F, Mol Imm, 1/1/2004
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: